Work experience

Jul 1996-Sep 2000  Yi Ji Shan Hospital, Wan nan Medical College

Jul 2003-Dec 2005  Sun Yat-sen University Cancer Center

Dec 2005-Dec 2010  Attending Physician. Sun Yat-sen University Cancer Center.

Dec 2010-present  Associate Professor Medical Oncolgy, Sun Yat-sen University Cancer Center.

1991-1996   Wan Nan Medical College, WuHu City, AnHuiProvince, P. R. China. Bachelor of Medicine (equivalent to US MD)

2000-2003   Yat-sen University, Guangzhou, P. R. China.Master of Medicine in Oncology

2005-2009   Yat-sen University, Guangzhou, P. R. China. Doctordegree of Medicine in Oncology

1. Zhang DS, Wang DS,Wang ZQ, Wang FH, Luo HY, Qiu MZ, Wang F, Li YH, Xu RH. Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabineadministered to Chinese patients with advanced pancreatic cancer. Cancer Chemother Pharmacol. 2013Apr;71(4):1065-72. doi: 10.1007/s00280-013-2102-4. Epub 2013 Mar 13.

2. Li S, Zhang DS (co-first author), Sun J, Li Z, Deng L, Zou B, Zhan J, Jiang W Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonalantibody in Chinese patients with CD22-positive non-Hodgkin lymphoma.MAbs. 2012 Mar 1;4(2). [Epub ahead of print]

3. Qiu MZ, Zhang DS (co-firstauthor), Ruan DY, Luo HY, Wang ZQ, Zhou ZW, Wang FH, Li YH, Xu RH. A relationship between ABO blood groups and clinicopathologiccharacteristics of patients with gastric adenocarcinoma in China.Med Oncol. 2011 Dec;28 Suppl 1:S268-73.doi: 10.1007/s12032-010-9735-5. Epub 2010 Nov 4.

4. Liu TZ, Zhang DS, LiangY, Zhou NN, Gao HF, Liu KJ, Wu HY Treatment strategiesand prognostic factors of patients with primary germ cell tumors in themediastinum. JCancer Res Clin Oncol. 2011 Nov;137(11):1607-12. doi:10.1007/s00432-011-1028-7. Epub 2011 Aug 18.

5. Wang DS, ZhangDS, Qiu MZ, Wang ZQ, Luo HY, Wang FH, Li YH, Xu RH. Prognostic factors and survival in patients with neuroendocrine tumors ofthe pancreas. Tumour Biol. 2011 Aug;32(4):697-705. doi: 10.1007/s13277-011-0170-9. Epub 2011Apr 9.

6. Qiu MZ, Wang ZQ, ZhangDS, Luo HY, Zhou ZW, Wang FH, Li YH, Jiang WQ, Xu RH. Clinicopathological characteristics and prognostic analysis of gastriccancer in the young adult in China. Tumour Biol. 2011 Jun;32(3):509-14. doi:10.1007/s13277-010-0145-2. Epub 2010 Dec 23.

7. Qiu MZ, Wang ZQ, ZhangDS, Liu Q, Luo HY, Zhou ZW, Li YH, Jiang WQ, Xu RH. Comparison of 6th and 7th AJCC TNM staging classification for carcinomaof the stomach in China. Ann Surg Oncol. 2011 Jul;18(7):1869-76. doi:10.1245/s10434-010-1542-x. Epub 2011 Jan 19.

8. Qiu MZ, Cai MY, ZhangDS, Wang ZQ, Wang DS, Li YH, Xu RH. Clinicopathologicalcharacteristics and prognostic analysis of Lauren classification in gastricadenocarcinoma in China.J Transl Med. 2013 Mar 6;11:58. doi: 10.1186/1479-5876-11-58.

9. Wang F, Xu RH, Luo HY, Zhang DS, Jiang WQ, Huang HQ, Sun XF, Xia ZJ, Guan ZZ. Clinical and prognostic analysis of hepatitis B virus infection indiffuse large B-cell lymphoma. BMC Cancer. 2008 Apr 23;8:115. doi:10.1186/1471-2407-8-115.

10. ZHANG Dong-sheng; JIANG Wen-qi;LI Su; et al. Expression of Glycoprotein 90K in Non-Hodgkin sLymphoma and Its Clinical  Significance .Chinese Journal of Cancer 2005;08.

11. ZHANGDong-sheng; JIANG Wen-qi; LI Su; et al. Detection of serun 90K/Mac-2BP in non-Hodgkin slymphoma and its clinical significance.Chian Oconlogy,2006；6.

Updated by International Office, Sun Yat-sen University Cancer Center